Market highlights for next week: JNJ, GOOG, INTC, YHOO to report
Posted Oct 12th 2007 4:00PM by Eric Buscemi
Filed under: Earnings Reports, Conventions and Conferences, Google (GOOG), Yahoo! (YHOO), eBay (EBAY), Intel (INTC), General Motors (GM), Johnson and Johnson (JNJ), Altria Group (MO), Novartis AG ADS (NVS), Merck and Co (MRK), Genentech Inc (DNA), Harley-Davidson (HOG)
.gif)
Monday October 15
- PDUFA date for Johnson & Johnson's (NYSE: JNJ) Doripenem for complicated intra-abdominal infection, complicated urinary tract infection
- PDUFA date for Bristol Myers Squibb Company (NYSE: BMY)/Elan Corporation's (NYSE: ELN) Tysabri (Natalizumab), a treatment for moderately to severely active Crohn's Disease
- PDUFA date for Merck & Co Inc's (NYSE: MRK) Januvia (Sitagliptin Phosphate) an adjunct to diet and exercise and as add-on therapy to a sulfonylurea in non-insulin dependent diabetes melliltus (NIDDM)/Type 2 Diabetes; add-on therapy to the combination of a sulfonylurea plus metformin in non-insulin depedent diabetes mellitus (NIDDM)Type 2 diabetes
Tuesday October 16
- PDUFA date for YY (NYSE: NVS) Tasigna (Nilotinib) for chronic myleoid leukemia/acute lymphoblastic leukemia
- Johnson & Johnson to report Q3 earnings; conference call at 8:30am
- Yahoo! Inc (NASDAQ: YHOO) to report Q3 earnings; conference call at 5pm
- Intel Corporation (NASDAQ: INTC) to report Q3 earnings; conference call at 5:30pm
Wednesday October 17
- PDUFA date for Merck's Isentress (Raltegravir), formerly MK-0518, for treatment for Human Immunodeficiency Virus (HIV) infection
- Altria Group Inc (NYSE: MO) to report Q3 earnings; conference call at 9am
- eBay Inc (NASDAQ: EBAY) to report Q3 earnings; conference call at 5pm
Thursday October 18
Friday October 19
- Harley Davidson Inc (NYSE: HOG) to report Q3 earnings; conference call at 9am
- PDUFA date for Cardiome Pharma Corporation's (NASDAQ: CRME) IV Vernakalant, an intravenous formulation of an investigational drug being evaluated for the acute conversion of atrial fibrillation
- PDUFA date for Indevus Pharmaceuticals Inc's (NASDAQ: IDEV) Valstar, for the therapy of bacillus Calmette-Guerin - refractory carcinoma in situ of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.
- PDUFA date for DOR BioPharma Inc's (OTC: DORB) orBec (Oral Beclomethasone Dipropionate) for Gastrointestinal Graft-Vs-Host Disease
- PDUFA date for Bristol Myers Squibb's Ixabepilone; monotherapy to treat patients with metastatic or locally advanced breast cancer after failure of chemotherapies
- PDUFA date for Genentech Inc's (NYSE: DNA)/Roche Holdings Ltd's (OTC: RHHBY) Herceptin (Trastuzumab); in combination with taxotere as first-line treatment of HER-2 positive metastatic breast cancer
Visit AOL Money & Finance for more earnings coverage
Get the latest on
cars and
trucksfrom GM and all brands at AOL Autos.
Reader Comments (Page 1 of 1)
10-12-2007 @ 11:07PM
semi- said...
re PDUFA date 10/15/2007 (Monday) The partners for Tysabri are ELN/BIIB (NOT BMY/ELN)